MARTEK BIOSCIENCES CORP (MATK)
Symbol Info
Listed Symbol MATK
Name MARTEK BIOSCIENCES CORP
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2010-10-01
Latest Fiscal Revenue $450,023,000
Latest Fiscal EPS $0.83
Price Info
21 Day Moving Average $31.4791
21 Day EMA $31.413750
50 Day Moving Average $31.4572
50 Day EMA $30.309890
200 Day EMA $26.390140
200 Day Moving Average 24.404120
52 Week High $32.75
52 Week Low $17.95
52 Week Change $39.336300
Alpha 0.005568
Beta 0.7578
Standard Deviation 0.125156
R2 0.099315
Periods 59
Share Information
10 Day Average Volume 382,335
20 Day Average Volume 370,713
30 Day Average Volume 444,850
50 Day Average Volume 614,368
Outstanding Shares 33,519,548
Float Shares 33,519,548
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 257
Institute Holdings Date 2011-01-01
Institute Bought Previous 3 Months 6,532,860
Institute Holdings Percent -
Institute Sold Previous 3 Months 6,026,136
Insider Holdings Date 2011-01-01
Insider Bought Previous 3 Months -
Insider Holdings Percent 2.80%
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $0.0300007
21 Day Percent Change 0.10%
30 Day Price Change $0.0300007
30 Day Percent Change 0.10%
Month To Date Price Change $-
Month To Date Percent -
90 Day Price Change $8.389999
90 Day Percent Change 36.32%
Quarter To Date $0.190001
Quarter To Date Percent 0.61%
180 Day Price Change $9.539999
180 Day Percent Change 43.46%
200 Day Price Change $11.309999
200 Day Percent Change 56.05%
Year To Date $0.190001
Year To Date Percent 0.61%
Profile
Description
Details
Issue Type CS
Market Cap $1,055,530,567
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding -
CEO Mr. Steve Dubin
Employees 592
Last Audit UQ
Classification
CIK 0000892025
Industry
Sector
NAICS Biological Product (except Diagnostic) Manufacturing(325414)
Info
Address 6480 Dobbin Road
Columbia, MD 21045
Website www.martekbio.com
Facisimile (410) 740-2985
Telephone (410) 740-0081
Email investors@martek.com
Key Ratios
Profitability
EBIT Margin 11.30
EBITDA Margin 27.5
Pre-Tax Profit Margin 13.4
Profit Margin Cont 6.20
Gross Margin 54.20
Profit Margin TOT 6.20
Income Statements
Revenue $450,023,000
Revenue Per Share $13.4257
Revenue 3 Years $11.95
Revenue 5 Years $13.71
Valuation Measures
PE Ratio 37.90
Enterprise Value $-
Price To Sales 2.345504
Price To Free Cash -13
PE High Last 5 Years -
Price To Book 1.6
Price To Cash Flow 16.1
PE Low Last 5 Years -
Price To Tangible Book 3.1
Financial Strength
Total Debt To Equity 0.0
Int Coverage 14.2
Current Ratio 4.5
Leverage Ratio 1.2
Quick Ratio 2.5
Long Term Debt To Capital 0.01
Assets
Receivables Turnover 7.9
Invoice Turnover 2.00
Assets Turnover 0.60
Management Effectiveness
Return Assets 3.50
Return On Equity 4.20
Return On Capital 4.10
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
MATK
Martek
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.